We are live on ! Find out more
WST icon

West Pharmaceutical
WST

406 hedge funds and large institutions have $9.57B invested in West Pharmaceutical in 2019 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 143 increasing their positions, 134 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

100% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 32

12% more capital invested

Capital invested by funds: $8.52B → $9.57B (+$1.05B)

9% more funds holding

Funds holding: 374 → 406 (+32)

7% more repeat investments, than reductions

Existing positions increased: 143 | Existing positions reduced: 134

0.89% less ownership

Funds ownership: 92.4% → 91.52% (-0.89%)

85% less call options, than puts

Call options by funds: $7.21M | Put options by funds: $47.8M

Holders
406
Holders Change
+32
Holders Change %
+8.56%
% of All Funds
8.9%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
64
Increased
143
Reduced
134
Closed
32
Calls
$7.21M
Puts
$47.8M
Net Calls
-$40.5M
Net Calls Change
+$3.68M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$71.8M
2
Brown Advisory
Brown Advisory
Maryland
+$26.3M
3
Morgan Stanley
Morgan Stanley
New York
+$25.4M
4
BlackRock
BlackRock
New York
+$24.6M
5
N
Nuveen
North Carolina
+$24.4M

Top Sellers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
-$118M
2
UIM
USS Investment Management
United Kingdom
-$76.2M
3
EAM
Eagle Asset Management
Florida
-$39.7M
4
CTA
Carillon Tower Advisers
Florida
-$29.5M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$22.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
NFG
251
Next Financial Group
Texas
$627K +$46.4K +337 +8%
GH
252
GAM Holding
Switzerland
$606K +$588K +4,271 New
BRWA
253
B. Riley Wealth Advisors
Florida
$595K +$99.7K +724 +21%
Nomura Asset Management
254
Nomura Asset Management
Japan
$593K -$559K -4,060 -49%
BWA
255
Burt Wealth Advisors
Maryland
$585K – – –
WAM
256
World Asset Management
Michigan
$569K -$2.34K -17 -0.4%
SDIC
257
South Dakota Investment Council
South Dakota
$567K – – –
SCA
258
Summit Creek Advisors
Minnesota
$555K +$538K +3,910 New
LIA
259
LS Investment Advisors
Michigan
$554K -$3.85K -28 -0.7%
Fifth Third Bancorp
260
Fifth Third Bancorp
Ohio
$551K +$80.7K +586 +18%
BOC
261
Barbara Oil Co
Illinois
$525K – – –
EGM
262
Engineers Gate Manager
New York
$522K -$231K -1,680 -31%
Commonwealth Equity Services
263
Commonwealth Equity Services
Massachusetts
$519K -$9.09K -66 -2%
CI Investments Inc
264
CI Investments Inc
Ontario, Canada
$503K +$489K +3,549 New
KFA
265
Krane Funds Advisors
New York
$502K +$458K +3,330 +1,609%
PGAM
266
Princeton Global Asset Management
New Jersey
$493K – – –
QT
267
Quantbot Technologies
New York
$490K +$424K +3,083 +822%
SM
268
Sciencast Management
New Jersey
$480K +$461K +3,349 New
ZIM
269
Zacks Investment Management
Illinois
$476K +$462K +3,357 New
FAAS
270
First Allied Advisory Services
California
$474K +$23.1K +168 +5%
SI
271
Stephens Inc
Arkansas
$472K +$3.44K +25 +0.8%
HIM
272
Hillsdale Investment Management
Ontario, Canada
$468K +$454K +3,300 New
GC
273
Guggenheim Capital
Illinois
$467K +$82.3K +598 +22%
AI
274
Atria Investments
North Carolina
$464K +$451K +3,274 New
C
275
Cerebellum
California
$434K +$16.7K +121 +4%
9 10
11
12 13

WST Hedge Fund Activity: Q3 2019 in Review

406 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2019, worth a combined $9.57B — up 12% from $8.52B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new WST positions and 32 closed out — a net gain of 32 holders — while 143 added to existing stakes and 134 trimmed.

The largest buyer was Millennium Management, adding an estimated $71.8M. The largest seller was AllianceBernstein, cutting an estimated $118M.

  • 406 institutional investors held West Pharmaceutical (WST) as of Q3 2019, up from 374 in Q2 2019.
  • Funds reported $9.57B of West Pharmaceutical stock for Q3 2019, up 12% quarter-over-quarter.
  • 64 funds opened new West Pharmaceutical positions in Q3 2019 and 32 closed out, a net change of +32 holders.
  • The largest West Pharmaceutical buyer in Q3 2019 was Millennium Management, an estimated $71.8M added.
  • The largest West Pharmaceutical seller in Q3 2019 was AllianceBernstein, an estimated $118M sold.

Based on aggregated 13F filings for Q3 2019.